Nicholas Company’s Allergan plc AGN.PRA Stock Holding History

Nicholas Company’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,520	Closed	-$9.65M	–	222
2017 Q4	$9.65M	Buy	16,520 +2,050	+14%	+$1.32M	0.21%	110
2017 Q3	$10.6M	Buy	14,470 +2,205	+18%	+$1.83M	0.24%	106
2017 Q2	$10.6M	Sell	12,265 -5	-0%	-$4.19K	0.24%	101
2017 Q1	$10.4M	Buy	12,270 +5,310	+76%	+$4.4M	0.24%	97
2016 Q4	$5.3M	Buy	+6,960	New	+$5.26M	0.12%	141

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Nicholas Company's AGN.PRA Position: Q1 2018 in Review

Nicholas Company sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 16,520 shares — an estimated $9.65M sold.

Nicholas Company first reported a position in AGN.PRA in Q4 2016 and held it in 5 quarters. The position peaked at $10.6M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Nicholas Company reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Nicholas Company sold 16,520 Allergan plc shares in Q1 2018, an estimated $9.65M.
Nicholas Company first reported a position in Allergan plc in Q4 2016 and held it in 5 quarters.
Nicholas Company's Allergan plc position peaked at $10.6M in Q2 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Nicholas Company's 13F filing for Q1 2018, filed 14 May 2018.